公开(公告)号：EP1629341A2

公开(公告)日：2006-03-01

申请号：EP03809129.4

申请日：2003-10-15

申请人： Medtronic Inc.

发明人： OSORIO, Ivan ,  FREI, Mark, G. ,  RISE, Mark, T. ,  SCHAFFNER, Scott, F. ,  GRAVES, Nina, M.

IPC分类号： G06F1/00

CPC分类号： A61N1/36025 ,  A61N1/08 ,  A61N1/36082

摘要： Apparatuses and methods support multi-modal operation of a medical device system for a nervous system disorder. The medical device system comprises an implanted component (953) and an external component (950) and supports a first feature and a second feature that are associated with the treatment therapy. The medical device system supports both features when the implanted component (953) and the external component (950) are coupled. If the external component (950) is decoupled, the implanted component (953) continues to support the first feature. Moreover, the embodiment may support a plurality of features during a treatment interval. Another aspect of the invention allows for modularly expanding a medical device system in order to add a feature that enhances existing functionality or that provides additional functionality. In an embodiment, a module that is associated with an external component (950) of the medical device system supports the added feature.

公开(公告)号：EP1583464B1

公开(公告)日：2014-04-09

申请号：EP03779123.3

申请日：2003-10-15

申请人： Medtronic, Inc.

发明人： FREI, Mark, G. ,  OSORIO, Ivan ,  GRAVES, Nina, M. ,  SCHAFFNER, Scott, F. ,  RISE, Mark, T. ,  GIFTAKIS, Jonathon, E. ,  CARLSON, David, L.

IPC分类号： A61B5/00

CPC分类号： A61B5/04012 ,  A61B5/0476 ,  A61B5/4094 ,  A61B5/7217 ,  A61N1/36025 ,  A61N1/36082 ,  A61N1/361 ,  Y10S128/92

公开(公告)号：EP1583464A2

公开(公告)日：2005-10-12

申请号：EP03779123.3

申请日：2003-10-15

申请人： Medtronic Inc.

发明人： FREI, Mark, G. ,  OSORIO, Ivan ,  GRAVES, Nina, M. ,  SCHAFFNER, Scott, F. ,  RISE, Mark, T. ,  GIFTAKIS, Jonathon, E. ,  CARLSON, David, L.

IPC分类号： A61B5/00

CPC分类号： A61B5/04012 ,  A61B5/0476 ,  A61B5/4094 ,  A61B5/7217 ,  A61N1/36025 ,  A61N1/36082 ,  A61N1/361 ,  Y10S128/92

摘要： Apparatus and method support a repetitive administration of a therapeutic treatment through a delivery unit during a neurological event, such as a seizure, of a nervous system disorder. The medical device system monitors signal data from a sensor and through an amplifier. A neurological event is detected by a medical device system using a detection algorithm. Consequently, a electrical stimulation pulse is applied to an electrode. During the delivery of the electrical stimulation pulse, the medical device system blanks signal data that is associated with the electrode. Subsequently, additional blanking is providing during a time interval in which signal artifacts may occur and the amplifier is stabilizing. The medical device system then collects signal data for the detection algorithm to stabilize. Subsequently, the medical device system collects additional signal data in order to obtain statistically meaningful data. If the medical device system detects a continuation of the seizure, therapeutic treatment continues.

公开(公告)号：EP1558130A2

公开(公告)日：2005-08-03

申请号：EP03809096.5

申请日：2003-10-15

申请人： Medtronic Inc.

发明人： OSORIO, Ivan ,  FREI, Mark, G. ,  BHAVARAJU, Naresh C. ,  PETERS, Thomas, E. ,  GRAVES, Nina, M. ,  SCHAFFNER, Scott, F. ,  GIFTAKIS, Jonathon, E. ,  RISE, Mark, T. ,  WERDER, Jonathan, C.

IPC分类号： A61B5/00

CPC分类号： A61N1/08 ,  A61B5/0476 ,  A61B5/4094 ,  A61B5/7275 ,  A61N1/36025 ,  A61N1/36082 ,  A61N1/361 ,  A61N1/37217

摘要： Apparatus (100) and method support a neurological event screening for a medical device. The medical device (100) assists a user in determining a configuration of the medical device for delivering an effective treatment for a nervous system disorder. The medical device detects a neurological event, such as a seizure, and reports a neurological event focus location and a neurological event spread to the user. The user may use the information to provide a configuration of a therapeutic delivery unit and associated therapy parameters. Therapeutic treatment is delivered to the patient, and the medical device is provided an indication of the patient's acceptance to the treatment. The user may modify the configuration and therapy parameters in order to achieve efficacy and acceptance. Depending upon the patient's acceptance, therapy is applied in either an open loop mode or a closed loop mode. The medical device determines whether the treatment is successful in accordance with a criterion.